Nanoparticles in intraocular drug delivery

Area of Science:

• Ophthalmology
• Nanotechnology
• Drug Delivery

Background:

• Visual impairment is a significant global health issue.
• Treating posterior eye diseases, particularly retinal conditions, faces drug delivery challenges.
• Current ocular drug delivery methods have limitations.

Purpose of the Study:

• To review challenges in ocular drug delivery for posterior eye diseases.
• To explore the potential of nanotherapy, specifically nanoparticles (NP), for ocular treatment.
• To examine how NP can address current gaps in treating eye diseases like diabetic retinopathy (DR).

Main Methods:

• Literature review focusing on nanotherapy for ocular drug delivery.
• Analysis of ocular changes relevant to nanotherapeutic approaches.
• Case illustration using diabetic retinopathy (DR) as an example.

Main Results:

• Nanoparticles show promise for targeted drug delivery to the posterior eye segment.
• Nanotherapy can potentially overcome limitations of conventional ocular drug delivery.
• Understanding ocular pathophysiology is crucial for effective nanotherapeutic design.

Conclusions:

• Nanoparticles represent a viable strategy to improve drug delivery for posterior eye diseases.
• Further research into NP-based ocular therapies is warranted.
• Nanotherapy holds potential to significantly advance the treatment of visual impairment.